Diabetes drug shows promise in fighting advanced prostate cancer
Disease control
Not yet recruiting
This study is testing if adding a common diabetes drug, dapagliflozin, to standard hormone therapy helps control advanced prostate cancer that has spread and stopped responding to standard hormone treatments. It will involve 60 men whose cancer has spread and who are starting a s…
Phase: PHASE2 • Sponsor: Yung NA • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC